Navigation Links
The secret sex life of the penicillin-producing fungus could make it more productive
Date:1/14/2013

New and more effective strains of the fungus used to produce penicillin could be developed after a team of international scientists unearthed the secret sex life of Sir Alexander Fleming's fungus Penicillium chrysogenum (P. chrysogenum).

The scientists from The University of Nottingham, Ruhr-University Bochum, The University of Gttingen, and Sandoz GmbH have announced a major breakthrough in our understanding of the sex life of the fungus P. chrysogenum. Their research looks sets to lead to the introduction of new and more effective strains of the world's first antibiotic agent and has been published online in the leading academic journal Proceedings of the National Academy of Sciences USA (PNAS).

Penicillium chrysogenum is a filamentous fungus of major medical and historical importance. It is the original and present-day industrial source of the antibiotic penicillin. For over 100 years the fungus has been thought to be asexual, but the researchers have discovered a method to entice the fungus into sexual reproduction. They've demonstrated that sexual crosses can be used to develop new strains with improved industrial characteristics.

Dr Paul Dyer, an expert in the sexual development and genetics of filamentous fungi in the School of Biology at Nottingham, said: "We now have a valuable tool for creating new strains of P. chrysogenum with increased penicillin production. This will make it cheaper to produce penicillin, as using more efficient strains will lower production costs. In the future, it is hoped our method can be applied to other fungi that produce antibiotics."

Our method might also be used to help discover hidden sexual cycles in other economically important fungi that are assumed to be exclusively asexual."

The development of penicillin

Penicillium chrysogenum first came to attention in 1928 when Sir Alexander Fleming made the fortuitous discovery that a Penicillium mold, which had contaminated a bacterial culture, was able to inhibit the growth of nearby bacteria by releasing penicillin into its surroundings. Over 10 years later two scientists, Ernst Chain and Howard Florey, were the first to grow the fungus in large quantities to generate enough penicillin to treat patients. These events heralded the start of the antibiotic era, which has been one of the most important advances in medicine. Fleming, Chain, and Florey later shared the Nobel Prize in physiology/medicine. Since then it has only been possible to develop strains of P. chrysogenum with elevated production of penicillin by conventional mutagenesis.

The researchers found that sexual reproduction could be induced in P. chrysogenum when strains were mated in the dark on oatmeal with a vitamin supplement. They demonstrated that the sexual cycle could be used for strain development purposes by producing offspring with new combinations of important biotechnological properties for penicillin production, such as the removal of chrysogenin, a contaminating substance produced by the fungus. Furthermore, the team discovered that mating-type genes, which control sex in fungi, have additional roles regulating other developmental processes of biotechnological relevance.

Inducing sex in celibate fungi

Fungi are used to produce many important pharmaceutical products including statins and antibiotics, and most species involved have long been considered to be asexual. But the present findings suggest that sexual reproduction could be triggered in other supposedly asexual fungi if the mating-type genes and correct growth conditions can be identified.


'/>"/>
Contact: Lindsay Brooke
lindsay.brooke@nottingham.ac.uk
44-011-595-15751
University of Nottingham
Source:Eurekalert

Related biology news :

1. The secrets of a tadpoles tail and the implications for human healing
2. Host cholesterol secretion likely to influence gut microbiota
3. Secrets of gentle touch revealed
4. Biologists unlocking the secrets of plant defenses, 1 piece at a time
5. Fitness for toad sperm: The secret is to mate frequently
6. Pond skating insects reveal water-walking secrets
7. Biophysicists unravel secrets of genetic switch
8. Ancient genome reveals its secrets
9. New model gives hands-on help for learning the secrets of molecules
10. Decoding the secrets of balance
11. Hidden secrets in the worlds most northerly rainforests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... and BEIJING , Nov. ... leading commercial provider of genomic services and solutions with ... today that it has completed a USD $75 Million ... Bank Co., Ltd.,s CMB International Capital Management ( ... Investment Management Co., Ltd. ("SDIC Innovation") and Shanghai Sigma ...
(Date:11/30/2016)... November 30, 2016 Part of 5m$ ... ... Aptuit, LLC today announced that it had successfully ... 150,000 novel compounds have increased the Screening Collection to over ... hit discovery capabilities of the company. This expansion, complemented by ...
(Date:11/30/2016)... (PRWEB) , ... November 30, 2016 , ... SSCI, the ... to discuss the implications of the latest FDA guidance on pharmaceutical cocrystals as ... 2016 in Cambridge, MA. , The event follows the successful November 15th ...
(Date:11/30/2016)... ... November 30, 2016 , ... T3D Therapeutics, Inc., a clinical ... treatment for Alzheimer’s disease (AD), today announced that CEO, John Didsbury, will be ... T3D-959 in mild to moderate Alzheimer’s patients at CTAD 2016. Preliminary results of ...
Breaking Biology Technology: